Middle East Africa Antinuclear Antibody Test Market Companies

The market is segmented based on Middle East and Africa Anti-Nuclear Antibody Test Market Segmentation, By Antibody Type (Extractable Nuclear Antigens (ENA), Anti-DSDNA & Histones, Anti-DFS70 Antibodies, Anti-PM-SCL, Anti-Centromere Antibodies, Anti-SP100, and Others), Product (Instruments, Consumables and Reagents, and Services), Technique (ELISA, Indirect ImmunoFluorescence (IIF), Blotting Test, Antigen Microarray, Gel Based Techniques, Multiplex Assay, Flow Cytometry, Passive Haemagglutination (PHA), and Others), Application (Autoimmune Diseases and Infectious Diseases), By End User (Hospitals, Laboratories, Diagnostic Centers, Research Institutes and Others), Distribution Channel (Direct Tender, Retail Sales, and Third Party Distributor and Others) - Industry Trends and Forecast to 2032 .

The Middle East Africa Antinuclear Antibody Test Market size was valued at USD 124.62 USD Million in 2024.

The Middle East Africa Antinuclear Antibody Test Market is projected to grow at a CAGR of 11.7% during the forecast period of 2025 to 2032.

The major players operating in the market include Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Abbott, Euroimmun Medizinische Labordiagnostika AG, ZEUS Scientific Inc. .

The market report covers data from the Middle East and Africa.